Literature DB >> 28332716

miR-124 and miR-9 mediated downregulation of HDAC5 promotes neurite development through activating MEF2C-GPM6A pathway.

Xi Gu1, Congcong Fu1, Lifang Lin2, Shuhu Liu1, Xiaohong Su1, Aili Li1, Qiaoqi Wu1, Chunhong Jia3, Peidong Zhang1, Lu Chen1, Xinhong Zhu4, Xuemin Wang1.   

Abstract

The class IIa histone deacetylases (HDACs) play important roles in the central nervous system during diverse biological processes such as synaptic plasticity, axon regeneration, cell apoptosis, and neural differentiation. Although it is known that HDAC5 regulates neuronal differentiation, neither the physiological function nor the regulation of HDAC5 in neuronal differentiation is clear. Here, we identify HDAC5 as an inhibitor of neurite elongation and show that HDAC5 is regulated by the brain enriched microRNA miR-124 and miR-9. We discover that HDAC5 inhibits neurite extension both in differentiated P19 cells and primary neurons. We also show that the neuronal membrane glycoprotein GPM6A (M6a) is a direct target gene of HDAC5 regulated transcriptional factor MEF2C. HDAC5 inhibits neurite elongation, acting at least partially via a MEF2C/M6a signaling pathway. We also confirmed the miR-124/miR-9 regulated HDAC5-MEF2C-M6a pathway regulates neurite development in primary neurons. Thus, HDAC5 emerges as a cellular conductor of MEF2C and M6a activity and is regulated by miR-124 and miR-9 to control neurite development.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  GPM6A; HDAC5; miR-124; miR-9; neurite development

Mesh:

Substances:

Year:  2017        PMID: 28332716     DOI: 10.1002/jcp.25927

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  22 in total

1.  In Vivo and In Vitro Neuronal Plasticity Modulation by Epigenetic Regulators.

Authors:  Melisa C Monteleone; María Eugenia Pallarés; Silvia C Billi; Marta C Antonelli; Marcela A Brocco
Journal:  J Mol Neurosci       Date:  2018-06-22       Impact factor: 3.444

Review 2.  MicroRNA-Directed Neuronal Reprogramming as a Therapeutic Strategy for Neurological Diseases.

Authors:  Irene Faravelli; Stefania Corti
Journal:  Mol Neurobiol       Date:  2017-06-29       Impact factor: 5.590

3.  miR-124 promotes proliferation and neural differentiation of neural stem cells through targeting DACT1 and activating Wnt/β-catenin pathways.

Authors:  Shujie Jiao; Yaling Liu; Yaobing Yao; Junfang Teng
Journal:  Mol Cell Biochem       Date:  2018-05-21       Impact factor: 3.396

4.  The protective role of the miR-25-mediated notch signaling pathway in the memory capacity and brain tissue of mice with central nervous system infections.

Authors:  Lizhou Wang; Tianpeng Jiang; Xueqing Huang; Shi Zhou
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

5.  Identification of differentially expressed microRNAs and their target genes in the hippocampal tissues of Fmr1 knockout mice.

Authors:  Malan Zhang; Xin Li; Du Xiao; Tao Lu; Bing Qin; Zhigang Zheng; Yonggen Zhang; Yi Liu; Tiebin Yan; Xinjia Han
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

6.  Histone deacetylase 4 shapes neuronal morphology via a mechanism involving regulation of expression of vascular endothelial growth factor D.

Authors:  Christian Litke; Hilmar Bading; Daniela Mauceri
Journal:  J Biol Chem       Date:  2018-04-09       Impact factor: 5.157

7.  Identification of hub miRNA biomarkers for bladder cancer by weighted gene coexpression network analysis.

Authors:  Feng Zhao; Yu-Zheng Ge; Liu-Hua Zhou; Lu-Wei Xu; Zheng Xu; Wen-Wen Ping; Min Wang; Chang-Cheng Zhou; Ran Wu; Rui-Peng Jia
Journal:  Onco Targets Ther       Date:  2017-11-22       Impact factor: 4.147

8.  MEF2C and HDAC5 regulate Egr1 and Arc genes to increase dendritic spine density and complexity in early enriched environment.

Authors:  Shu Juan Puang; Bavani Elanggovan; Tendy Ching; Judy C G Sng
Journal:  Neuronal Signal       Date:  2020-07-23

Review 9.  Insights Into the Function and Clinical Application of HDAC5 in Cancer Management.

Authors:  Jun Yang; Chaoju Gong; Qinjian Ke; Zejun Fang; Xiaowen Chen; Ming Ye; Xi Xu
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

Review 10.  Treating Parkinson's disease by astrocyte reprogramming: Progress and challenges.

Authors:  Zhuang-Yao D Wei; Ashok K Shetty
Journal:  Sci Adv       Date:  2021-06-23       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.